Dermatology

Top Story

Five recent developments in psoriasis

Five recent developments in psoriasis
June 23, 2017

Research finding that patients with psoriasis have a prevalence of certain comorbidities that contribute to metabolic syndrome was among recent developments reported on Healio.com/Dermatology.

Other developments included findings that tildrakizumab showed efficacy as treatment for patients with moderate-to-severe chronic plaque psoriasis compared with placebo or Enbrel, and an expert panel’s recommended guidelines for patients with pediatric psoriasis:

Meeting News

Managing dermatologic conditions requires patience, careful diagnosis

June 23, 2017
PHILADELPHIA — Given that some dermatological conditions present similar symptoms, it is critical for nurse practitioners and primary care physicians to make the…
In the Journals

Calcium hydroxylapatite shows efficacy in treating hand volume loss for up to 1 year

June 23, 2017
A single treatment with calcium hydroxylapatite dermal filler for volume loss in the dorsum of the hands showed improvement for up to 12 months posttreatment, according…

Novartis reports $11.5 billion in quarterly sales

June 23, 2017
Novartis reported net sales of $11.5 billion in the first quarter compared with $11.6 billion in the same quarter of 2016, according to a press release. Net income was…
In the Journals

Disease burden of atopic dermatitis comparable to psoriasis

June 23, 2017
Patients with atopic dermatitis had health-related quality of life and productivity impairment that was comparable to patients with psoriasis, according to recently…
More News Headlines »
Advertisement
Advertisement